Evidence map›Paper›PMID 38538009›Full record

ArticleRespiratory care2024

Albuterol Delivery via In-Line Intrapulmonary Percussive Ventilation Superimposed on Invasive Ventilation in an Adult Lung Model.

Takashi Karashima, Yuka Mimura-Kimura, Yusuke Mimura

Open access · bronzeAbstract read
In one paragraph

Article in Respiratory care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Takashi KarashimaDepartment of Medical Engineering, National Hospital Organization Yamaguchi Ube Medical Center, Ube, Japan.
Yuka Mimura-KimuraDepartment of Clinical Research, National Hospital Organization Yamaguchi Ube Medical Center, Ube, Japan.
Yusuke MimuraDepartment of Clinical Research, National Hospital Organization Yamaguchi Ube Medical Center, Ube, Japan mimura.yusuke.qy@mail.hosp.go.jp.
National Sanyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntrapulmonary percussive ventilation (IPV) is frequently used for airway clearance, together with delivery of aerosolized medications. Drug delivery via IPV alone increases with decreasing percussion frequency and correlates with tidal volume ([Formula: see text]), whereas drug delivery via IPV during invasive ventilation is not well characterized. We hypothesized that drug delivery via IPV-invasive ventilation would differ from IPV alone due to control of ventilation by invasive ventilation.

methodsAn adult ventilator circuit was used for IPV-invasive ventilation. A normal or a diseased lung model was configured to airway resistance of 5 cm H

resultsThe maximum efficiency of albuterol delivery via IPV-invasive ventilation was not different from that via IPV alone (mean ± SD of loading dose, 3.7 ± 0.2% vs 4.2 ± 0.3%, respectively;

conclusionsAlbuterol delivery via IPV-invasive ventilation was modulated by percussion frequency but was not increased with increasing [Formula: see text]. The delivery efficiency was not sufficiently high for clinical use, in part due to nebulizer retention and extrapulmonary deposition.

Indexed as

AlbuterolBronchodilator AgentsLungRespiration, ArtificialAdministration, InhalationAdultAirway ResistanceDrug Delivery SystemsHumansLung ComplianceModels, AnatomicModels, BiologicalNebulizers and VaporizersPositive-Pressure RespirationTidal VolumeAlbuterolBronchodilator Agentsalbuteroldrug deliveryintrapulmonary percussive ventilationmechanical ventilation

Identifiers

PMID38538009
PMCPMC11349587
OpenAlexW4393224436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.